1261512-49-5 Usage
Uses
Used in Pharmaceutical Research and Development:
5-Bromo-2-methoxybenzodifluoride is used as a building block for the synthesis of various pharmaceuticals. Its unique chemical properties and reactivity make it suitable for a wide range of chemical reactions, contributing to the development of new and innovative drugs.
Used in Agrochemical Production:
5-Bromo-2-methoxybenzodifluoride is also used in the production of agrochemicals, where it serves as a key intermediate in the synthesis of various agricultural chemicals. Its versatility and reactivity enable the creation of effective and targeted agrochemicals for crop protection and other agricultural applications.
Used in Specialty Chemicals Manufacturing:
5-Bromo-2-methoxybenzodifluoride is utilized in the manufacturing of specialty chemicals, where its unique properties and reactivity are harnessed to produce a variety of high-value chemical products for diverse industries, such as fragrances, dyes, and other industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1261512-49-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,1,5,1 and 2 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1261512-49:
(9*1)+(8*2)+(7*6)+(6*1)+(5*5)+(4*1)+(3*2)+(2*4)+(1*9)=125
125 % 10 = 5
So 1261512-49-5 is a valid CAS Registry Number.
1261512-49-5Relevant articles and documents
Ph2S/selectfluor-promoted deoxydifluorination of aldehydes
He, Guowen,Xiao, Xuan,Jin, Han-Zhou,Lin, Jin-Hong,Zhong, Tongsheng,Zheng, Xing,Xiao, Ji-Chang
, (2021)
The installation of a HCF2 group is a research area that has received increasing attention, and deoxydifluorination of aldehydes have served as an attractive protocol due to the wide availability of aldehydes. Herein we describe a Ph2/sub
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES
-
, (2015/04/15)
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).